
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Context-dependent role of SIRT3 in cancer
Jin Zhang, Jing Ye, Shiou Zhu, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 2, pp. 173-190
Closed Access | Times Cited: 13
Jin Zhang, Jing Ye, Shiou Zhu, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 2, pp. 173-190
Closed Access | Times Cited: 13
Showing 13 citing articles:
2-APQC, a small-molecule activator of Sirtuin-3 (SIRT3), alleviates myocardial hypertrophy and fibrosis by regulating mitochondrial homeostasis
Peng Fu, Minru Liao, Wenke Jin, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 23
Peng Fu, Minru Liao, Wenke Jin, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 23
Therapeutic strategies of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancer
Xin Jin, Wenke Jin, L. Tong, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2815-2853
Open Access | Times Cited: 8
Xin Jin, Wenke Jin, L. Tong, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2815-2853
Open Access | Times Cited: 8
Mitochondrial Sirtuins in Cancer: A Revisited Review from Molecular Mechanisms to Therapeutic Strategies
Hui Shen, Wei Ma, Yue Hu, et al.
Theranostics (2024) Vol. 14, Iss. 7, pp. 2993-3013
Open Access | Times Cited: 7
Hui Shen, Wei Ma, Yue Hu, et al.
Theranostics (2024) Vol. 14, Iss. 7, pp. 2993-3013
Open Access | Times Cited: 7
Targeting sirtuins for cancer therapy: epigenetics modifications and beyond
Hui Shen, Xinyi Qi, Yue Hu, et al.
Theranostics (2024) Vol. 14, Iss. 17, pp. 6726-6767
Open Access | Times Cited: 7
Hui Shen, Xinyi Qi, Yue Hu, et al.
Theranostics (2024) Vol. 14, Iss. 17, pp. 6726-6767
Open Access | Times Cited: 7
Roles of SIRT3 in cardiovascular and neurodegenerative diseases
Liang Chen, Anqi Zhao, Ying Li, et al.
Ageing Research Reviews (2025), pp. 102654-102654
Closed Access
Liang Chen, Anqi Zhao, Ying Li, et al.
Ageing Research Reviews (2025), pp. 102654-102654
Closed Access
GLP-1 Therapy in Cancer and Its Mechanism
Baowen Zhang, Jingyi Zhang
Theoretical and Natural Science (2025) Vol. 89, Iss. 1, pp. 71-77
Closed Access
Baowen Zhang, Jingyi Zhang
Theoretical and Natural Science (2025) Vol. 89, Iss. 1, pp. 71-77
Closed Access
Function of intramitochondrial melatonin and its association with Warburg metabolism
R.J. Reiter, Ramaswamy Sharma, Yidong Bai, et al.
Cellular Signalling (2025), pp. 111754-111754
Open Access
R.J. Reiter, Ramaswamy Sharma, Yidong Bai, et al.
Cellular Signalling (2025), pp. 111754-111754
Open Access
Sirtuin 3 Protects Lung Adenocarcinoma from Ferroptosis by Deacetylating and Stabilizing Mitochondrial Glutamate Transporter Solute Carrier Family 25 Member A22
Xiangyun Wei, Tiange Wang, Zhengcao Xing, et al.
Antioxidants (2025) Vol. 14, Iss. 4, pp. 403-403
Open Access
Xiangyun Wei, Tiange Wang, Zhengcao Xing, et al.
Antioxidants (2025) Vol. 14, Iss. 4, pp. 403-403
Open Access
Functions and mechanisms of non-histone post-translational modifications in cancer progression
Zongyang Li, Tao Zhu, Yushu Wu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Zongyang Li, Tao Zhu, Yushu Wu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Discovery of a novel small-molecule activator of SIRT3 that inhibits cell proliferation and migration by apoptosis and autophagy-dependent cell death pathways in colorectal cancer
Yi Mou, Yanmei Chen, Zhichao Fan, et al.
Bioorganic Chemistry (2024) Vol. 146, pp. 107327-107327
Closed Access | Times Cited: 4
Yi Mou, Yanmei Chen, Zhichao Fan, et al.
Bioorganic Chemistry (2024) Vol. 146, pp. 107327-107327
Closed Access | Times Cited: 4
Sirt1: An Increasingly Interesting Molecule with a Potential Role in Bone Metabolism and Osteoporosis
Yi Chen, Hefang Xiao, Zirui Liu, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 970-970
Open Access | Times Cited: 4
Yi Chen, Hefang Xiao, Zirui Liu, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 970-970
Open Access | Times Cited: 4
Design, synthesis and biological evaluation of novel SIRT3 inhibitors targeting both NAD+ and substrate binding sites for the treatment of acute myeloid leukemia
Xuetao Yang, Ge Ge, Hailing Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116689-116689
Closed Access | Times Cited: 1
Xuetao Yang, Ge Ge, Hailing Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116689-116689
Closed Access | Times Cited: 1
Design, synthesis and biological evaluation of new SIRT3 activators for the treatment of triple-negative breast cancer
G Huang, Yi Li, Xi Zhao, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 118, pp. 118040-118040
Closed Access
G Huang, Yi Li, Xi Zhao, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 118, pp. 118040-118040
Closed Access
The Expression of SIRT3 in Endometrial Carcinoma and Its Effect on Promoting Apoptosis of Ishikawa Cells
Xinyu Zhao, Xiaojian Yin
Biochemical Genetics (2024)
Closed Access
Xinyu Zhao, Xiaojian Yin
Biochemical Genetics (2024)
Closed Access